![]()
20
| 1 | 2007
Klinisk Biokemi i Norden
Litteratur:
1. Carmel R. Current concepts in cobalamin defici-
ency. Annu Rev Med 2000; 51:357-375.
2. Andrès E, Loukili HN, Noel E et al. Vitamin B12
(cobalamin) deficiency in elderly patients. CMAJ
2004; 171:251-259.
3. Nexø E. Vitamin B12-mangel. Medicinsk årbog
1999.
4. Carmel R. Measuring and interpreting holo-
Transcobalamin (holo-Transcobalamin II). Clinical
Chemistry 2002; 48:3.
5. Lloyd-Wright Z, Hvas AM, Møller J, Sanders TAB,
Nexø E. Holotranscobalamin as an indicator of
dietary vitamin B12 deficiency. Clinical Chemistry
2003; 49:2.
6. Schneede J, Ueland PM. Novel and established
markers of cobalamin deficiency: complementary
or exclusive diagnostic strategies. Review. Semin
Vasc Med 2005; 5:140-155.
7. Hvas AM, Ellegaard J, Nexø E. Vitamin B12
treatment normalizes metabolic markers but has
limited clinical effect: a randomized placebo-con-
trolled study. Clinical Chemistry 2001; 47:8.
8. Hvas AM, Ellegaard J, Nexø E. Diagnostik af vita-
min B12-mangel – tid til eftertanke. Ugeskr Læger
2003; 165:19.
9. Ermens AAM., Vlasveld LT, Lindemans J.
Significance of elevated cobalamin (vitamin
B12) levels in blood. Clinical Biochemistry 2003;
36:585-590.
10. Carmel R, Vasireddy H, Aurangzeb I, George K.
High serum cobalamin levels in the clinical setting
– clinical associations and holo-transcobalamin
changes. Clin Lab Haem 2001; 23:365-371.
11. Torgano G, Mandelli K, Massaro P, Abbiati C et
al. Gastroduodenal lesions in polycythaemia vera:
frequency and role of Helicobacter pylori. British
Journal of Haematology 2002; 117:198-202.
12. Refsum H, Smith AD, Ueland PM, Nexø E, Clarke
R, McPartlin J, Johnston C, Engbaek F, Schneede
J, McPartlin C, Scott JM. Facts recommendations
about total homocysteine determinations: an
expert opinion. Clinical Chemistry 2004; 50:3-32.
13. Hvas AM, Nexø E. Holotranscobalamin - a first
choice assay for diagnosing early vitamin B12
deficiency? Journal of Internal Medicine 2005;
257: 289-298.
14. Morkbak AL, Heimdal RM, Emmens K, Molloy
A, Hvas AM, Schneede J, Clarke R, Scott JM,
Ueland PM, Nexo E. Evaluation of the tech-
nical performance of novel holotranscobala-
min (holoTC) assays in a multicenter European
demonstration project. Clin Chem Lab Med 2005;
43(10):1058-64.
15. Chen X, Remacha AF, Sarda MP, Carmel R.
Influence of cobalamin deficiency compared with
that of cobalamin absorption on serum holo-trans-
cobalamin II. Am J Clin Nutr 2005; 81(1):110-4.
16. Nexø E, Hvas AM, Bleie Ø, Refsum H, Fedosov NS,
Vollset SE, Schneede J, Nordrehaug JE, Ueland
PM, Nygard OK. Holo-Transcobalamin is an early
marker of changes in cobalamin homeostasis. A
randomized placebo-controlled study. Clinical
Chemistry 2002; 48:1768-1771.
17. Fowler B. Genetic defects of folate and cobalamin
metabolism. Eur J of Pediatr 1998; 157:S60-S66.
18. Bor MV, Nexo E, Hvas AM. Holo-transcobala-
min concentration and transcobalamin satura-
tion reflect recent vitamin B12 absorption better
than does serum vitamin B12. Clin Chem 2004;
50(6):1043-9.
19. Refsum H, Johnston C, Guttormsen AB, Nexo E.
Holotranscobalamin and total transcobalamin
in human plasma: determination, determinants,
and reference values in healthy adults. Clin Chem
2006; 52(1):129-37.
20. Morkbak AL, Hvas AM, Lloyd-Wright Z, Sanders
TA, Bleie O, Refsum H, Nygaard OK, Nexo E. Effect
of vitamin B12 treatment on haptocorrin. Clin
Chem 2006; 52(6):1104-11.
21. Nexo E, Nooroya B, Hvas AM, Christensen AL,
Waters H. Autoantibodies against intrinsic factor
(IF) measured with an ELISA using recombinant
human IF as both catching and detecting reagent.
Clin Chem Lab Med 2005; 43(4):351-6.
22. Bor MV, Cetin M, Aytac S, Altay C, Nexo
E. Nonradioactive vitamin B12 absorpti-
on test evaluated in controls and in patients
with inherited malabsorption of vitamin B12.
Clin Chem 2005; 51(11):2151-5.
23. Hvas AM, Buhl H, Laursen NB, Hesse B, Berglund
L, Nexo E. The effect of recombinant human
intrinsic factor on the uptake of vitamin B12 in
patients with evident vitamin B12 deficiency.
Haematologica 2006; 91(6):805-8.
